OK
The other posters feel that with your knowledge of the company you might be able to enlighten us on how YOU would have run a biotech company with 4 phase 3 trials on the go in regards to ongoing capital requirements We all understand the last 6 months may not have gone to plan but these decisions were made between 2011 and 2017
And if you can successfully enunciate a plan you would have put in place would you like to run for a board position? We have a desire for constructive ideas that will forward the rapidly developing and changing science which MSB is at the forefront
MSB Holders Only, page-440
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.045(4.00%) |
Mkt cap ! $1.335B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.18 | $1.13 | $4.980M | 4.315M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 73090 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 27903 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |